| EMA number | EMEA/H/C/002073 |
| ATC code | C09XA53 |
| Authorisation | 14 April 2011 |
| Withdrawn | 25 June 2015 |
| Revision | 7 |
Rasilamlo is indicated for the treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled with aliskiren or amlodipine used alone.